ETC
ARNA

Exchange Traded Concepts’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Exchange Traded Concepts’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,022
Closed -$675K – 1210
2020
Q3 		$675K Buy
+9,022
New +$602K 0.04% 230

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Exchange Traded Concepts's ARNA Position: Q4 2020 in Review

Exchange Traded Concepts sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 9,022 shares — an estimated $675K sold.

Exchange Traded Concepts first reported a position in ARNA in Q3 2020 and held it in 1 quarter. The position peaked at $675K in Q3 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Exchange Traded Concepts reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Exchange Traded Concepts sold 9,022 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $675K.
  • Exchange Traded Concepts first reported a position in Arena Pharmaceuticals Inc in Q3 2020 and held it in 1 quarter.
  • Exchange Traded Concepts's Arena Pharmaceuticals Inc position peaked at $675K in Q3 2020.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Exchange Traded Concepts's 13F filing for Q4 2020, filed 19 Jan 2021.